TY - JOUR
T1 - The feasibility and effectiveness of using an adhesion barrier in preventing dysmenorrhea, pain, and niche-related problems after cesarean sections
T2 - a multicenter randomized pilot study
AU - Post, B L
AU - Verberkt, C
AU - van Veen, D
AU - van der Voet, L
AU - Bongers, M Y
AU - de Boer, M A
AU - Wortelboer, E J
AU - Huirne, J A F
AU - de Leeuw, R A
PY - 2025/10
Y1 - 2025/10
N2 - Background: A cesarean scar can lead to various gynecological complaints, including abdominal pain, dysmenorrhea, postmenstrual spotting, and unexplained secondary infertility. The ethiology of the development of a niche is currently not clear. A possible hypothesis is the involvement of vesicouterine adhesions formed after the cesarean section. Objective: This study explores the feasibility of a randomized controlled trial assessing the effectiveness of an adhesion barrier on the uterine wound in women undergoing their first cesarean section on gynecological symptoms and the presence of adhesions evaluated by transvaginal ultrasound (TVUS). Study design: A multicenter randomized pilot study was performed on women undergoing their first cesarean section. They were randomly allocated to the application of the adhesion barrier 4DryField® PH after uterine closure or no adhesion barrier. They were followed for 9 months using TVUS and questionnaires. The primary outcome measure was feasibility (protocol compliance, loss-to-follow-up, data collection). Secondary outcomes were perioperative outcomes, menstrual outcomes, Quality of Life, and sexual function at 9 months, as well as ultrasound findings such as vesicouterine adhesion and niche measurements at 3 months. Results: One hundred and seventeen participants (58 intervention, 59 control) were enrolled. Protocol adherence was 94.8% to 100%, and follow-up loss was 3% to 12%. Difficulties in feasibility included ultrasound evaluation, ultrasound storage, and participant recall bias. At 9 months, 40% of participants had amenorrhea and/or gave breastfeeding or used hormonal contraceptives. There was no apparent difference in dysmenorrhea, but postmenstrual spotting was less in the intervention group (0% vs 18.4%, P=.04). Furthermore, there was a trend toward fewer adhesions and niches in the intervention group. Conclusion: The study showed no clear limitations, feasible execution of the procedure, and a low drop-out rate. Spotting was less in the intervention group. Nevertheless, a larger sample size is needed to draw solid conclusions concerning the beneficial effect of reducing niches, adhesions, dysmenorrhea, and chronic pelvic pain. Our findings are encouraging and support the design of a comparatively large randomized controlled trial with a refined methodology to enhance feasibility and accuracy.
AB - Background: A cesarean scar can lead to various gynecological complaints, including abdominal pain, dysmenorrhea, postmenstrual spotting, and unexplained secondary infertility. The ethiology of the development of a niche is currently not clear. A possible hypothesis is the involvement of vesicouterine adhesions formed after the cesarean section. Objective: This study explores the feasibility of a randomized controlled trial assessing the effectiveness of an adhesion barrier on the uterine wound in women undergoing their first cesarean section on gynecological symptoms and the presence of adhesions evaluated by transvaginal ultrasound (TVUS). Study design: A multicenter randomized pilot study was performed on women undergoing their first cesarean section. They were randomly allocated to the application of the adhesion barrier 4DryField® PH after uterine closure or no adhesion barrier. They were followed for 9 months using TVUS and questionnaires. The primary outcome measure was feasibility (protocol compliance, loss-to-follow-up, data collection). Secondary outcomes were perioperative outcomes, menstrual outcomes, Quality of Life, and sexual function at 9 months, as well as ultrasound findings such as vesicouterine adhesion and niche measurements at 3 months. Results: One hundred and seventeen participants (58 intervention, 59 control) were enrolled. Protocol adherence was 94.8% to 100%, and follow-up loss was 3% to 12%. Difficulties in feasibility included ultrasound evaluation, ultrasound storage, and participant recall bias. At 9 months, 40% of participants had amenorrhea and/or gave breastfeeding or used hormonal contraceptives. There was no apparent difference in dysmenorrhea, but postmenstrual spotting was less in the intervention group (0% vs 18.4%, P=.04). Furthermore, there was a trend toward fewer adhesions and niches in the intervention group. Conclusion: The study showed no clear limitations, feasible execution of the procedure, and a low drop-out rate. Spotting was less in the intervention group. Nevertheless, a larger sample size is needed to draw solid conclusions concerning the beneficial effect of reducing niches, adhesions, dysmenorrhea, and chronic pelvic pain. Our findings are encouraging and support the design of a comparatively large randomized controlled trial with a refined methodology to enhance feasibility and accuracy.
KW - Cesarean section
KW - adhesion barrier
KW - adhesions
KW - dysmenorrhea
KW - feasibility
KW - niche
KW - randomized controlled trial
KW - spotting
U2 - 10.1016/j.ajogmf.2025.101742
DO - 10.1016/j.ajogmf.2025.101742
M3 - Article
SN - 2589-9333
VL - 7
JO - American Journal of Obstetrics & Gynecology MFM
JF - American Journal of Obstetrics & Gynecology MFM
IS - 10
M1 - 101742
ER -